Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Livro
|
Farnesyltransferase Inhibitors in Cancer TherapySaid M. Hamilton, Andrew Sebti Andrew D Hamilton; Said M Sebti; Andrew HamiltonHumana Press 2001Acesso online |
|
2 |
Material Type: Artigo
|
Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumoursZHANG, X ; BLASKOVICH, M. A ; FORINASH, K. D ; SEBTI, S. MBritish journal of cancer, 2014-08, Vol.111 (5), p.894-902 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
|
3 |
Material Type: Artigo
|
The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membraneBerndt, N ; Yang, H ; Trinczek, B ; Betzi, S ; Zhang, Z ; Wu, B ; Lawrence, N J ; Pellecchia, M ; Schönbrunn, E ; Cheng, J Q ; Sebti, S MCell death and differentiation, 2010-11, Vol.17 (11), p.1795-1804 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
4 |
Material Type: Artigo
|
A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1 Mek-1 Erk1 2 pathwayCARIEL, A. E ; SEBTI, S. MOncogene, 2007-05, Vol.26 (26), p.3777-3788 [Periódico revisado por pares]Basingstoke: Nature PublishingTexto completo disponível |
|
5 |
Material Type: Artigo
|
Identification of novel ROCK inhibitors with anti-migratory and anti-invasive activitiesPatel, R A ; Liu, Y ; Wang, B ; Li, R ; Sebti, S MOncogene, 2014-01, Vol.33 (5), p.550-555 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
6 |
Material Type: Artigo
|
Farnesyltransferase and geranylgeranyltransferase I inhibitors upregulate RhoB expression by HDAC1 dissociation, HAT association and histone acetylation of the RhoB promoterDELARUE, F. L ; ADNANE, J ; CHELLAPPAN, S ; SEBTI, S. M ; JOSHI, B ; BLASKOVICH, M. A ; WANG, D.-A ; HAWKER, J ; BIZOUARN, F ; OHKANDA, J ; ZHU, K ; HAMILTON, A. DOncogene, 2007-02, Vol.26 (5), p.633-640 [Periódico revisado por pares]Basingstoke: Nature PublishingTexto completo disponível |
|
7 |
Material Type: Artigo
|
Antitumor efficacy of a novel class of non-thiol-containing peptidomimetic inhibitors of farnesyltransferase and geranylgeranyltransferase I : Combination therapy with the cytotoxic agents cisplatin, taxol, and gemcitabineJIAZHI SUN ; BLASKOVICH, M. A ; KNOWLES, D ; YIMIN QIAN ; OHKANDA, J ; BAILEY, R. D ; HAMILTON, A. D ; SEBTI, S. MCancer research (Chicago, Ill.), 1999-10, Vol.59 (19), p.4919-4926 [Periódico revisado por pares]Philadelphia, PA: American Association for Cancer ResearchTexto completo disponível |
|
8 |
Material Type: Artigo
|
Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenograftsSUN, J ; YIMIN QIAN ; HAMILTON, A. D ; SEBTI, S. MOncogene, 1998-03, Vol.16 (11), p.1467-1473 [Periódico revisado por pares]Basingstoke: Nature PublishingTexto completo disponível |
|
9 |
Material Type: Artigo
|
Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issuesSebti, Saïd M ; Hamilton, Andrew DExpert opinion on investigational drugs, 2000-12, Vol.9 (12), p.2767-2782 [Periódico revisado por pares]England: Ashley Publications LtdSem texto completo |
|
10 |
Material Type: Artigo
|
The farnesyl transferase inhibitor, FTI-277, inhibits growth and induces apoptosis in drug-resistant myeloma tumor cellsBOLICK, S. C. E ; LANDOWSKIL, T. H ; BOULWARE, D ; OSHIRO, M. M ; OHKANDA, J ; HAMILTON, A. D ; SEBTI, S. M ; DALTON, W. SLeukemia, 2003-02, Vol.17 (2), p.451-457 [Periódico revisado por pares]London: Nature PublishingTexto completo disponível |